In an initial exploratory analysis, we investigated the inflammatory and regulatory CD4+ T cell subsets in the peripheral blood of patients diagnosed with PsoA, RA, or SpA, compared to HCs. This evidence concerns the gene CD4 and rheumatoid arthritis.